Search Results for "Breast Pap Test Trial"

11:48 EDT 26th May 2015 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Blood Test for Breast Cancer

It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early. A team, led by Oxford University scientists, took te...

The Nottingham Prognostic Index Plus test for breast cancer management

The Nottingham Prognostic Index Plus test (NPI+) is a biomarker-based test developed by the University of Nottingham to support individualised clinical decision making in breast cancer treatment. The ...

New Test Predicts Which Early Breast Cancer Will Metastasize

A test that predicts breast cancer metastases may not be too far away. Unlike other panels, this test checks for the three-cell structure found at sites of extravasation. Medscape Medical News

CASI Starts China Arm of Phase II Breast Cancer Trial

CASI Pharma, a US biopharma with strong China connections, has begun a China Phase II trial of its lead molecule, ENMD-2076, in triple-negative breast cancer. The trial is a China arm of an on-going P...

Zinc Test Could Help Diagnose Breast Cancer Early

A team, led by Oxford University scientists, took techniques normally used to analyze trace metal isotopes for studying climate change and planetary formation and applied them to how the human body pr...

Gene Test May Help Predict Return of Early Breast Tumor, Study Says

FRIDAY, Dec. 12, 2014 -- For women who have early breast tumors surgically removed, a new genetic test may help predict the odds of a recurrence, a new study says. The research, presented Friday at th...

Income inequality affects who gets an underutilized test for breast cancer

Wealthier women who live in communities with the greatest income divide between rich and poor had better access to a new genetic test that can determine the most effective form of treatment for early-...

Income inequality affects who gets an underutilised test for breast cancer

Wealthier women who live in communities with the greatest income divide between rich and poor had better access to a new genetic test that can determine the most effective form of treatment for early-...

Matching PubMed Articles

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.

The aim of this study was to examine whether EndoPredict (EP), a novel genomic expression test, is effective in predicting local recurrence (LR)-free survival (LRFS) following surgery for breast cance...

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial.

Metformin has therapeutic potential against breast cancer, but the mechanisms of action in vivo remain uncertain. This study examined biomarker effects of metformin in primary breast cancer in a preop...

Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis.

Background. Mammographic breast density is one of the strongest independent risk factors for developing breast cancer. We examined the effect of exemestane and tamoxifen on breast density in Dutch pos...

Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population.

Background:There is a need for interventions to promote uptake of breast screening throughout Europe.Methods:We performed a single-blind randomised controlled trial to test whether text-message remind...

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

For most older women with early breast cancer, standard treatment after breast-conserving surgery is adjuvant whole-breast radiotherapy and adjuvant endocrine treatment. We aimed to assess the effect ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement